Skip to main content
Fig. 1 | Trials

Fig. 1

From: Phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections (PRICE-2): study protocol for a phase 3 randomized controlled trial

Fig. 1

Schedule of enrollment, interventions, and assessments. POD, postoperative day; Hx, history; DM, diabetes mellitus; AIDS, acquired immunodeficiency syndrome; CKD, chronic kidney disease; CHF, congestive heart failure; MI, myocardial infarction; PUD, peptic ulcer disease; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; CVA, cardiovascular accident; TIA, transient ischemic attack; PVE, portal vein embolization; Hgb, hemoglobin; INR, international normalized ratio; AST, aspartate transaminase; ALT, alanine transaminase; GGT, gamma-glutamyl transpeptidase; ALP, alkaline phosphatase; CA 19-9, carbohydrate antigen 19-9; CEA, carcinoembryonic antigen; AFP, alpha-fetoprotein; GFR, glomerular filtration rate; CVP, central venous pressure; PPV, pulse pressure variation; MAP, mean arterial pressure; RBC, red blood cell

Back to article page

Trials

ISSN: 1745-6215